Hypertonic/hyperoncotic solution in hypovolemic patients: experience in the emergency room.
Hypertonic solutions have been studied extensively in the treatment of hypovolemic shock, both in experimental and clinical models. Safety, efficacy, and long-term effects on animals and patients have been evaluated. The present article reviews indications, safety, mortality rates, and outcome in patients with hemorrhagic hypovolemic shock who were treated after admission with a hypertonic/hyperoncotic solution under strict observation in the emergency room.
Younes
Riad N
RN
Department of Surgery and LIM-62, Hospital das Clínicas, Faculty of Medicine, University of São Paulo.
Birolini
Dario
D
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D003911:Dextrans / Q000008:administration & dosage / Q000627:therapeutic use*; D004311:Double-Blind Method; D004630:Emergencies; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D010952:Plasma Substitutes / Q000627:therapeutic use*; D011379:Prognosis; D012462:Saline Solution, Hypertonic / Q000008:administration & dosage / Q000627:therapeutic use*; D012771:Shock, Hemorrhagic / Q000628:therapy*; D016896:Treatment Outcome
D003911:Dextrans; D010952:Plasma Substitutes; D012462:Saline Solution, Hypertonic